Issues
-
Cover Image
Cover Image
ABOUT THE COVER
Diffuse intrinsic pontine glioma (DIPG) is an incurable childhood brain cancer that commonly harbors somatic methionine substitutions in lysine 27 of histone 3 (H3 K27M). The image at right, on which the cover is based, shows a high-magnification hematoxylin and eosin (H&E) stained murine DIPG initiated by expression of platelet-derived growth factor-B (PDGF-B) and H3.3 K27M in nestin-expressing progenitors of the neonatal brainstem. The image illustrates an area of microvascular proliferation, a histological feature of a high-grade glioma. The cover is an artistic use of the image, kept intact but repeated and rotated for visual effect. Please see the article by Cordero and colleagues (beginning on page 1243) for more information. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Molecular Cancer Research
Table of Contents
Highlights
Review
Cell Death and Survival
Chromatin, Epigenetics, and RNA Regulation
DNA Damage and Repair
Genomics
Metabolism
Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer
Oncogenes and Tumor Suppressors
Signal Transduction
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.